CANNAINVESTOR Magazine October 2017 | Page 22

22

Roger Ferreira Ph.D.

Chief Executive Officer, Director

Management &

Directors

Dr. Ferreira received his PhD in neuroimmunology, with a focus on how brain inflammation can be curbed, especially relevant to the neural harm that occurs with neurodegenerative disease, and stroke. Roger has authored several peer-reviewed publications, and has presented his work at international conferences. His area of research is particularly relevant to medical marihuana, as there is evidence that cannabinoids can limit certain inflammation in the brain, an exciting area of research that will reveal how marihuana may affect symptoms of disease.

Mr. Panagiotakopoulos has spent 14 years in the Realestate development industry as the Owner and CEO Cardinal Group's land development division. He has built a career drafting, presenting, and negotiating government contracts. Further, Mr. Panagiotakopoulos has also spent five years as President and CEO of Hamilton Solar, developing renewable energy projects for the Ontario Power Authority. He has built Ontario's first large scale Elevated Solar Tracking array on commercial land. Mr. Panagiotakopoulos expertise in managing specialized development projects has allowed for cost effective project advancement.

Bill Panagiotakopoulos

Chief Operating Officer, Director

Mr. Krasic, an investment banking professional, began his career with Thomas Weisel Partners and later joined Stifel Nicolaus Canada gaining experience in finance structuring, providing valuations, exchange listings and various M&A transactions. Mr. Krasic has been instrumental in raising capital, and developing security and record keeping protocols as Beleave’s CFO. He holds an honours degree from the University of Toronto in Finance and Economics, and a Masters Degree in Investment Management with a specialization in Capital Markets from John Molson School of Buiness.

Bojan Krasic B.COMM, MIM

Chief Financial Officer, Director